In our study, we observed a significant presence of microvessels in gastric cancer following anti-CD47 treatment, leading us to discover that tumor angiogenesis plays a crucial role in limiting the effectiveness of anti-CD47 therapy for the first time. The gene discussed is CD47; the disease is neoplasm.